The Incremental Risk of Intraoperative Fentanyl on PONV
NCT ID: NCT03201315
Last Updated: 2019-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
363 participants
OBSERVATIONAL
2017-01-01
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Intravenous Patient-controlled Analgesia (IV-PCA) With Fentanyl in Adults for Acute Postoperative Pain Control
NCT01527890
Genetic Variants and Non-genetic Variables and Postoperative Nausea and Vomiting
NCT03490175
Reduction of Postoperative Pain, Nausea and Vomiting
NCT01718132
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
NCT02625181
Postoperative Nausea and Vomiting: to Estimate the Incidence and Risk Factors in a Tertiary Teaching Hospital
NCT02689128
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. to determine whether there is an independent association between the intraoperative administration of fentanyl (both as a continuous and categorical variable) and PONV within 24 postoperative hours
2. determine whether or not the intraoperative fentanyl amount can be used to successfully restratify patients for PONV beyond the simplified Apfel score for PONV
All required data is collected in regular daily practice. The following variables will be assessed by univariable models:
Preoperative variables (e.g. patient characteristics) Surgical/Anesthesia variables (e.g. type/length of surgery, antiemetics) Outcome variables (PONV, worst pain as delineated in the outcomes section), Intraoperative fentanyl measured 1) as a continuous variable and 2) by predefined limits of 0 to 0.2mg, \>0.2-0.5mg, \>0.5 to 0.8mg, and \>8mg.
Finally for the multivariable model, the investigators will adjust for confounders, specifically for sex (m/f), history (Hx) of PONV (y/n), Hx of motion sickness (y/n), current smoker (y/n), age (years), expected duration of surgery (min; \>60 min), postoperative opioids (y/n), the use of preemptive PONV Therapy (0,1,2 medications), propofol vs. inhalative agents (y/n), and surgery type (3 kinds) from the patient's electronic record. In the event that insufficient event rates are observed, we will collapse the variables into the simplified Apfel score to assess the independent value of fentanyl in predicting PONV.
In addition to a logistic model as delineated above, we will conduct the following:
1. receiver operating characteristic (ROC) curves of the logistic model without fentanyl, with fentanyl (continuous), and with fentanyl (categorical).
2. additionally, ROCs of a simplified model using the Apfel score, the Apfel score with fentanyl (continous), and the Apfel score with fentanyl (categorical) will be made. Comparison of area under the receiver operating characteristics(AUROCs) by DeLong
3. net reclassification improvement (NRI) of both the logistic model with and without fentanyl as well as the Apfel score with and without fentanyl
To assess pain and administered fentanyl, we will examine pain scores by the numeric rating scale (NRS).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged \>= 18 years, and
* Undergoing general anesthesia (with or without neuraxial or regional anesthesia.)
* in abdominal, gynecological or otorhinolaryngological surgery
Exclusion Criteria
* Patients with chronic pain, defined as recurring pain requiring intermittent hospitalization or regular intake of pain medication.
* Non-opioid naïve patients, defined as a history of abuse or having taken opioids within the last 30 days
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Bandschapp, PD Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Wilhelm Ruppen, PD Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Eckhard Mauermann, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
University Hospital Basel; University Hospital Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitiy Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mauermann E, Clamer D, Ruppen W, Bandschapp O. Association between intra-operative fentanyl dosing and postoperative nausea/vomiting and pain: A prospective cohort study. Eur J Anaesthesiol. 2019 Nov;36(11):871-880. doi: 10.1097/EJA.0000000000001081.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKNZ 2016-01605
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.